Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

[Lapatinib is useful for metastatic breast cancer patients who cannot be treated with trastuzumab-report of a case].

Hirano T, Sakurai K, Fujisaki S, Maeda T, Nagashima S, Hara Y, Tomita R, Suzuki S, Enomoto K, Amano S.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2045-7. Japanese.

PMID:
23267971
2.

Trastuzumab and chemotherapy after the treatment failure of lapatinib for HER2-positive metastatic breast cancer.

Suzuki Y, Saito Y, Terao M, Terada M, Morioka T, Tsuda B, Okamura T, Niikura N, Tokuda Y.

Tokai J Exp Clin Med. 2010 Dec 20;35(4):148-51.

3.

[A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer].

Yabe N, Murai S, Shimizu H, Kitasato K, Yoshikawa T, Oto I, Nakadai J, Jinno H, Kitagawa Y.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2396-8. Japanese.

PMID:
24394124
4.

[A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].

Sato T, Nakagawa T, Kuwayama T, Oda G, Sugimoto H, Ishiba T, Sugihara K.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2180-2. Japanese.

PMID:
22202322
5.

[Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].

Ohsako T, Inoue K, Nagamoto N, Yoshida Y, Nakahara O.

Gan To Kagaku Ryoho. 2006 Sep;33(9):1301-3. Japanese.

PMID:
16969029
6.

[Liver arterial infusion chemotherapy with adjuvant trastuzumab for the simultaneous treatment of liver and breast cancer-a case report].

Takahashi R, Fujii T, Inoue Y, Takahashi H, Akashi M, Nishida R, Takami Y, Saitsu H, Momosaki S, Nakayama Y, Uchino K, Takayoshi K, Shirouzu K.

Gan To Kagaku Ryoho. 2012 Nov;39(11):1707-10. Review. Japanese.

PMID:
23152024
7.

[A case of non-palpating breast cancer with huge lymph node metastasis].

Hara Y, Sakurai K, Fujisaki S, Nagashima S, Suzuki S, Shibata M, Tomita R, Matsumoto K, Enomoto K, Amano S.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2014-6. Japanese.

PMID:
22202269
8.

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.

Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Chinese.

PMID:
21029696
9.

[A case of trastuzumab-resistant breast cancer responding to lapatinib/capecitabine therapy].

Hayashi M, Orita M, Hironaka H, Morita N.

Gan To Kagaku Ryoho. 2014 Mar;41(3):353-5. Japanese.

PMID:
24743282
10.

Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer.

Blackwell KL, Burstein HJ, Storniolo AM, Rugo H, Sledge G, Koehler M, Ellis C, Casey M, Vukelja S, Bischoff J, Baselga J, O'Shaughnessy J.

J Clin Oncol. 2010 Mar 1;28(7):1124-30. doi: 10.1200/JCO.2008.21.4437. Epub 2010 Feb 1.

PMID:
20124187
11.

Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.

Medina PJ, Goodin S.

Clin Ther. 2008 Aug;30(8):1426-47. doi: 10.1016/j.clinthera.2008.08.008. Review.

PMID:
18803986
12.

[A case of breast cancer liver metastases with jaundice responding to trastuzumab monotherapy].

Ueda H, Nakagawa T, Sato T, Nagahara M, Sugihara K.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2068-70. Japanese.

PMID:
23267979
13.

[Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases].

Rai Y, Takahama T, Sagara Y, Sagara Y, Matsuyama Y, Ando M, Sagara Y, Ooi Y.

Gan To Kagaku Ryoho. 2006 Sep;33(9):1297-300. Japanese.

PMID:
16969028
14.

Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel.

Steger GG, Abrahámová J, Bacanu F, Brincat S, Brize A, Cesas A, Cufer T, Dank M, Duchnowska R, Eniu A, Jassem J, Kahán Z, Matos E, Padrik P, Plāte S, Pokker H, Purkalne G, Timcheva C, Tzekova V, Vyzula R, Zielinski CC.

Wien Klin Wochenschr. 2010 Jun;122(11-12):368-79. doi: 10.1007/s00508-010-1373-6. Epub 2010 Jun 15.

PMID:
20549373
15.

[A case of bilateral multiple primary breast cancer].

Waga E, Sakurai K, Fujisaki S, Maeda T, Nagashima S, Hara Y, Tomita R, Suzuki S, Enomoto K, Amano S.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2036-8. Japanese.

PMID:
23267968
17.

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer.

Ono M, Ando M, Yunokawa M, Nakano E, Yonemori K, Matsumoto K, Kouno T, Shimizu C, Tamura K, Katsumata N, Fujiwara Y.

Int J Clin Oncol. 2009 Feb;14(1):48-52. doi: 10.1007/s10147-008-0797-8. Epub 2009 Feb 20.

PMID:
19225924
18.

[Complete response of advanced breast cancer with lymph node metastases to nab-paclitaxel therapy-report of a case].

Hara Y, Sakurai K, Enomoto K, Matsumoto K, Ueda Y, Hagiwara M, Waga E, Nagashima S, Tani M, Amano S.

Gan To Kagaku Ryoho. 2012 Nov;39(12):2080-2. Japanese.

PMID:
23267983
19.
20.

[A case of advanced breast cancer with multiple lung and liver metastases successfully treated with multi-disciplinary therapy].

Sakurai K, Enomoto K, Amano S, Kitajima A, Suzuki M, Matsuo S, Sakamoto A, Kashio M, Tani M, Negishi N.

Gan To Kagaku Ryoho. 2005 Oct;32(11):1792-4. Japanese.

PMID:
16315943

Supplemental Content

Support Center